DONALD TAYLOR: Open Payments
NPI 1629278304 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$749 in 40 payments from 3 companies in 2025. Trend: 2023 $694 · 2024 $548 · 2025 $749
Food & beverage: $749
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 19 | $383 |
| E.R. Squibb & Sons, L.L.C. | 16 | $261 |
| Otsuka America Pharmaceutical, Inc. | 5 | $106 |
Products named: ARISTADA, COBENFY, ABILIFY ASIMTUFII.
Industry payments across CA — which companies pay providers there.
